Operating Income: The income after operating expenses.
ImmunityBio, Inc. (IBRX) had Operating Income of $-64.43M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$16.52M |
|
$-129.65M |
|
$0.06M |
|
$16.46M |
|
$80.95M |
|
|
Operating Income |
$-64.43M |
$-65.47M |
|
$-129.90M |
|
$-129.90M |
|
$-129.67M |
|
$-129.67M |
|
$-129.67M |
|
$-129.67M |
|
$-64.43M |
|
$-60.65M |
|
853.16M |
|
853.16M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$109.16M |
|
$135.27M |
|
$194.60M |
|
$303.76M |
|
$49.20M |
|
$485.72M |
|
$845.04M |
|
$894.24M |
|
$-590.48M |
|
$-605.92M |
|
$-590.48M |
|
853.56M |
|
| Cash Flow Statement Financials | |
$-85.91M |
|
$4.13M |
|
$-0.98M |
|
$143.91M |
|
$61.14M |
|
$-82.77M |
|
$9.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.22 |
|
-- |
|
-- |
|
-4.64 |
|
-0.82 |
|
99.65% |
|
-390.08% |
|
-390.08% |
|
-- |
|
-786.46% |
|
-784.92% |
|
$-87.03M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.01 |
|
0.97 |
|
92.79 |
|
21.96% |
|
21.40% |
|
-42.69% |
|
123.77% |
|
$-0.69 |
|
$-0.10 |
|
$-0.10 |
|